Department of Applied Psychology Medical University of Lublin Lublin Poland

Department of Hematology and Pediatrics Children's Hospital Warsaw Poland

Department of Pediatric Hematology and Oncology Charles University and University Hospital Motol Prague Czech Republic

Department of Pediatric Hematology Oncology and Transplantology Laboratory of Genetic Diagnostics Medical University of Lublin Lublin Poland

Department of Pediatric Hematology Oncology and Transplantology Medical University of Lublin Lublin Poland

Department of Pediatric Oncology and Hematology Children's Hospital Kielce Poland

Department of Pediatric Oncology and Hematology Children's University Hospital Jagiellonian University Kraków Poland

Department of Pediatric Oncology Hematology and Chemotherapy Medical University of Katowice Katowice Poland

Department of Pediatric Oncology Hematology and Transplantology Medical University of Poznań Poznań Poland

Department of Pediatric Oncology Hematology Medical University of Białystok Białystok Poland

Department of Pediatric Transplantology Oncology Hematology Medical University of Wrocław Wrocław Poland

Department of Pediatrics Hematology and Oncology Collegium Medicum of Bydgoszcz Bydgoszcz Poland

Department of Pediatrics Hematology and Oncology Medical University of Szczecin Szczecin Poland

Department of Pediatrics Hematology and Oncology Medical University of Zabrze Zabrze Poland

Department of Pediatrics Hematology Oncology and Endocrinology Medical University of Gdańsk Gdańsk Poland

Department of Pediatrics Oncology Hematology and Diabetology Medical University of Łódź Łódź Poland

Zobrazit více v PubMed

Stary J, Zimmermann M, Campbell M, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC‐BFM 2002. J Clin Oncol. 2014;32(3):174‐184. PubMed

Cui L, Li ZG, Chai YH, et al. Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG‐ALL 2008: The first nation‐wide prospective multicenter study in China. Am J Hematol. 2018;93(7):913‐920. PubMed

Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol. 2012;30(14):1663‐1669. PubMed PMC

Christensen MS, Heyman M, Mottonen M, et al. Treatment‐related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992‐2001. Br J Haematol. 2005;131(1):50‐58. PubMed

Moricke A, Zimmermann M, Valsecchi MG, et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP‐BFM ALL 2000. Blood. 2016;127(17):2101‐2112. PubMed

Moricke A, Reiter A, Zimmermann M, et al. Risk‐adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL‐BFM 95. Blood. 2008;111(9):4477‐4489. PubMed